Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

I have always believed in the underlying stem cell technology’s potential, but what elements UNIQUE TO THIS COMPANY exist to drive dramatically increased market cap, and how are these features any less present than they were, say, two years ago? For example, there is nothing meaningfully different about CaverStem—which alone of all the CELZ product lines had the potential to take a substantial chunk out of the established market shares of current ED treatments in a way that, if this scenario is realistic, should already have sent this stock to dollars (particularly when the PPS was .03 and the OS under 50M shares exactly one year ago)? I have yet to read any clear answers to the compelling business questions—including from the company itself...